| Bioactivity | KRASG12C IN-13 (LY3499446) is a potent KRAS G12C inhibitor. KRASG12C IN-13 is promising for research of advanced solid tumors including non-small cell lung cancer and colorectal cancer[1]. |
| CAS | 2409131-50-4 |
| Formula | C22H17ClF2N6OS |
| Molar Mass | 486.92 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Nagasaka M, et al. KRAS G12C Game of Thrones, which direct KRAS inhibitor will claim the iron throne? Cancer Treat Rev. 2020 Mar;84:101974. |
KRASG12C IN-13
CAS: 2409131-50-4 F: C22H17ClF2N6OS W: 486.92
KRASG12C IN-13 (LY3499446) is a potent KRAS G12C inhibitor. KRASG12C IN-13 is promising for research of advanced solid t
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.